DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 991.00M | 999.70M | 930.40M | 836.30M | 720.70M |
| Total Depreciation and Amortization | 291.70M | 280.80M | 275.60M | 268.50M | 261.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 233.90M | 270.80M | 259.10M | 232.50M | 205.50M |
| Change in Net Operating Assets | -102.20M | 197.40M | 317.40M | 103.40M | 260.80M |
| Cash from Operations | 1.41B | 1.75B | 1.78B | 1.44B | 1.45B |
| Capital Expenditure | -316.10M | -343.70M | -353.10M | -363.50M | -386.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -41.20M | -41.20M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 618.50M | 915.60M | 490.40M | 899.50M | 311.90M |
| Cash from Investing | 261.20M | 530.70M | 137.30M | 536.00M | -74.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.21B | -1.21B | -1.21B | -1.21B | -- |
| Issuance of Common Stock | 24.70M | 26.60M | 26.60M | 28.10M | 28.10M |
| Repurchase of Common Stock | -1.36B | -1.14B | -535.80M | -500.00M | -187.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.60M | -7.40M | -7.20M | -7.00M | -6.70M |
| Cash from Financing | -2.55B | -2.33B | -1.72B | -1.69B | -165.80M |
| Foreign Exchange rate Adjustments | -5.00M | -5.00M | 16.40M | 21.50M | 6.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -875.40M | -55.10M | 212.30M | 311.80M | 1.21B |